PepperLime Health Acquisition Corporation Warrrant
PEPLW
PEPLW was delisted on the 21st of March, 2024.
1 hedge funds and large institutions have $60 invested in PepperLime Health Acquisition Corporation Warrrant in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 16 closing their positions.
94% less funds holding
Funds holding: 17 → 1 (-16)
100% less capital invested
Capital invested by funds: $1.56M → $60 (-$1.56M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$1.43M |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$18.8K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$16.8K |
| 4 |
ACM
Altium Capital Management
New York
|
-$11.1K |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$10.5K |
PEPLW Hedge Fund Activity: Q1 2024 in Review
1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Warrrant (PEPLW) for Q1 2024, worth a combined $60 — down 100% from $1.56M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PEPLW and 0 opened new positions — a net loss of 16 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Boothbay Fund Management, exiting entirely with an estimated $1.43M sold.
- 1 institutional investor held PepperLime Health Acquisition Corporation Warrrant (PEPLW) as of Q1 2024, down from 17 in Q4 2023.
- Funds reported $60 of PepperLime Health Acquisition Corporation Warrrant stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new PepperLime Health Acquisition Corporation Warrrant positions in Q1 2024 and 16 closed out, a net change of -16 holders.
- The largest PepperLime Health Acquisition Corporation Warrrant seller in Q1 2024 was Boothbay Fund Management, an estimated $1.43M sold.
Based on aggregated 13F filings for Q1 2024.